Cargando…

Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California

BACKGROUND: Interferon Gamma Release Assays (IGRAs) and Tuberculin Skin Tests (TSTs) are important adjunctive pediatric TB diagnostics. This study analyzes the use and performance of IGRAs in children diagnosed with active TB disease in a high-resource, low-incidence setting. METHODS: We retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kay, Alexander, Islam, Shamim, Wendorf, Kristen, Westenhouse, Janice, Barry, Pennan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630727/ http://dx.doi.org/10.1093/ofid/ofx163.1640

Ejemplares similares

1392. Tuberculosis Disease in Recipients of Organ-Transplantation, California 2010–2017
por: Katrak, Shereen, et al.
Publicado: (2019)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Diagnostic Utility of Interferon-γ Release Assay in Tuberculous Lymphadenitis
por: Ye, Susu, et al.
Publicado: (2017)

Getting to Zero: Tuberculosis Elimination in California
por: Barry, Pennan M., et al.
Publicado: (2016)

789. Comparison of Interferon-γ Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients
por: Kulkarni, Prathit, et al.
Publicado: (2018)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
por: Little, Kristen M., et al.
Publicado: (2015)

Assessing the validity of tuberculosis surveillance data in California
por: Sprinson, Joan E, et al.
Publicado: (2006)

Influencial factors of the performance of interferon-γ release assays in the diagnosis of childhood tuberculosis
por: Li, Tao, et al.
Publicado: (2014)

Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014)

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020)

Analysis of Factors Lowering Sensitivity of Interferon-γ Release Assay for Tuberculosis
por: Hang, Nguyen Thi Le, et al.
Publicado: (2011)

Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis
por: Ai, Lu, et al.
Publicado: (2019)

Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California
por: Bakhsh, Yasser, et al.
Publicado: (2022)

Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010–2013
por: Peralta, Gianna, et al.
Publicado: (2016)

646. Increasing Use of Interferon-Gamma Release Assay to Test for Pediatric Tuberculosis in a Low-Burden Setting
por: Campbell, Jeffrey, et al.
Publicado: (2021)

Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area
por: Kim, Jong Keun, et al.
Publicado: (2013)

Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan
por: Nishimura, Tomoyasu, et al.
Publicado: (2018)

Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection
por: Yan, Marie, et al.
Publicado: (2023)

Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis
por: Banfield, Sally, et al.
Publicado: (2012)

790. The Efficacy of the Interferon-γ Releasing Assay-Based Isoniazid Treatment for Preventing Active Tuberculosis in Kidney Transplant Recipients: A Quasi-experimental Study
por: Kim, Hae-In, et al.
Publicado: (2018)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States()
por: Belanger, Annie, et al.
Publicado: (2019)

Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2019)

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
por: Lange, Christoph, et al.
Publicado: (2017)

Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children
por: Yun, Ki Wook, et al.
Publicado: (2016)

Combining interferon-γ release assays with lymphocyte enumeration for diagnosis of Mycobacterium tuberculosis infection
por: Lv, Dingfeng, et al.
Publicado: (2020)

Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010–2012
por: Demlow, Sarah Ellen, et al.
Publicado: (2015)

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013
por: Shah, Neha S., et al.
Publicado: (2016)

Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review
por: Overton, Kristen, et al.
Publicado: (2018)

Performance of Interferon-γ Release Assays in Patients with Mycobacterium kansasii Infection
por: Gao, Chun-Hai, et al.
Publicado: (2022)

Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014–2017
por: Readhead, Adam, et al.
Publicado: (2022)

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment
por: Park, I-Nae, et al.
Publicado: (2017)

Comparison of T-Cell Interferon-γ Release Assays for Mycobacterium tuberculosis-Specific Antigens in Patients with Active and Latent Tuberculosis
por: Kobashi, Yoshihiro, et al.
Publicado: (2010)

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
por: Metcalfe, John, et al.
Publicado: (2010)

Tuberculosis and HIV Co-infection, California, USA, 1993–2008
por: Metcalfe, John Z., et al.
Publicado: (2013)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015
por: Oh, Peter, et al.
Publicado: (2017)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Whole Blood Interferon-γ Release Assay Is Insufficient for the Diagnosis of Sputum Smear Negative Pulmonary Tuberculosis
por: Park, HeeJin, et al.
Publicado: (2014)

251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
por: Ondrejkova, Andrea, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3e4flvjoh6c2ssfg627hmk9cpa